Trending News
News

News
Celldex Acquires Exclusive Rights to Immune-stimulatory Molecules from Amgen
FMS-like tyrosine kinase 3 ligand and CD40 ligand among assets to be utilized in cancer and anti-inflammatory immunotherapies.

News
Scientist Plans $245M Research Institute on Health Care
Dietrich Stephan, founding scientist of TGen, plans to plot research institute focused on personalized medicine in a 300,000-square-foot building in Northern Virginia.

News
UT Southwestern Researchers Reveal How the Brain Processes Important Information
Researchers shed light on how the neurotransmitter dopamine helps certain brain cells to become more flexible and changes brain-cell circuitry.

News
Lab21 and BreastHealth UK Form Partnership for Breast Health Management
The partners will offer UK women personalized health management and predictive genetic testing for breast cancer risk.

News
FASgen Announces Research and License Agreement with Centocor
Centocor to discover and develop novel small molecule inhibitors of the fatty acid biosynthesis pathway via selective inhibition of FAS for use in Oncology.

News
Vampires Go to Bat for Stroke Treatment
The stroke experts are hoping a blood thinner that mimics a chemical in vampire saliva will help save brain cells in stroke patients.

News
Brain Starvation as We Age Appears to Trigger Alzheimer’s
A slow, chronic starvation of the brain as we age appears to be one of the major triggers of a biochemical process that causes some forms of Alzheimer's disease.

News
Celera and Abbott Revise Strategic Alliance from Profit Sharing to Worldwide Distribution and Royalty Agreements
New agreements include distribution arrangement for certain Celera products and royalty-bearing arrangement for m2000™ sales.

News
In Vitro Diagnostics Industry Welcomes Pathology Report
The British In Vitro Diagnostics Association has welcomes the publication of the report of the second phase of Lord Carter’s Independent Review of Pathology Services.

News
Champions Biotechnology Partners to Establish Agreements for Preclinical Evaluation of Oncology Drugs
Champions Biotechnology’s Biomerk Tumorgrafts™ will be utilized by the Centocor for the preclinical evaluation of certain therapeutic agents.
Advertisement